BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31429584)

  • 1. Toward a Synergistic Operating Model for Westmead Research Hub Biobanks: A Questionnaire Study.
    St George G; Wang XM; Linton J; Douglas N; Carpenter JE; Clarke CL; Heads JA
    Biopreserv Biobank; 2019 Dec; 17(6):570-576. PubMed ID: 31429584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks.
    Ling R; Rush A; Carter C; Carpenter J; Watson PH; Byrne JA; Searles A
    Biopreserv Biobank; 2018 Feb; 16(1):53-58. PubMed ID: 29215912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing Professionalization of Biobank Business Operations: Performance and Utilization.
    Henderson MK; Goldring K; Simeon-Dubach D
    Biopreserv Biobank; 2019 Jun; 17(3):213-218. PubMed ID: 31188630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Future of Biobanking: A Conceptual Look at How Biobanks Can Respond to the Growing Human Biospecimen Needs of Researchers.
    Somiari SB; Somiari RI
    Adv Exp Med Biol; 2015; 864():11-27. PubMed ID: 26420610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Certification for biobanks: the program developed by the Canadian Tumour Repository Network (CTRNet).
    Matzke EA; O'Donoghue S; Barnes RO; Daudt H; Cheah S; Suggitt A; Bartlett J; Damaraju S; Johnston R; Murphy L; Shepherd L; Mes-Masson AM; Schacter B; Watson PH
    Biopreserv Biobank; 2012 Oct; 10(5):426-32. PubMed ID: 24845043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing and sustaining a biorepository network in Israel: challenges and progress.
    Cohen Y; Almog R; Onn A; Itzhaki-Alfia A; Meir K
    Biopreserv Biobank; 2013 Dec; 11(6):331-8. PubMed ID: 24835362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biobank classification in an Australian setting.
    Rush A; Christiansen JH; Farrell JP; Goode SM; Scott RJ; Spring KJ; Byrne JA
    Biopreserv Biobank; 2015 Jun; 13(3):212-8. PubMed ID: 26035012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Business Planning in Biobanking: How to Implement a Tool for Sustainability.
    Ciaburri M; Napolitano M; Bravo E
    Biopreserv Biobank; 2017 Feb; 15(1):46-56. PubMed ID: 27898226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era.
    Chalmers D; Nicol D; Kaye J; Bell J; Campbell AV; Ho CW; Kato K; Minari J; Ho CH; Mitchell C; Molnár-Gábor F; Otlowski M; Thiel D; Fullerton SM; Whitton T
    BMC Med Ethics; 2016 Jul; 17(1):39. PubMed ID: 27405974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing Professionalization of Biobank Business Operations: A Worldwide Survey.
    Henderson MK; Goldring K; Simeon-Dubach D
    Biopreserv Biobank; 2019; 17(1):71-75. PubMed ID: 30412417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustainability in Biobanking: Model of Biobank Graz.
    Sargsyan K; Macheiner T; Story P; Strahlhofer-Augsten M; Plattner K; Riegler S; Granitz G; Bayer M; Huppertz B
    Biopreserv Biobank; 2015 Dec; 13(6):410-20. PubMed ID: 26697910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and Driving Forces for Business Plans in Biobanking.
    Macheiner T; Huppertz B; Bayer M; Sargsyan K
    Biopreserv Biobank; 2017 Apr; 15(2):121-125. PubMed ID: 28338345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical Financial Challenges for Biobanking: Report of a National Cancer Institute Study.
    Rao A; Vaught J; Tulskie B; Olson D; Odeh H; McLean J; Moore HM
    Biopreserv Biobank; 2019 Apr; 17(2):129-138. PubMed ID: 30638412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quality of biomaterials in liquid- and tissue-biobanking].
    Herpel E; Schmitt S; Kiehntopf M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):325-35. PubMed ID: 26753866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for a Dutch Sustainable Biobanking Environment.
    van der Stijl R; Manders P; Eijdems EWHM
    Biopreserv Biobank; 2021 Jun; 19(3):228-240. PubMed ID: 34042498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Plan for Academic Biobank Solvency-Leveraging Resources and Applying Business Processes to Improve Sustainability.
    Uzarski D; Burke J; Turner B; Vroom J; Short N
    Clin Transl Sci; 2015 Oct; 8(5):553-7. PubMed ID: 25996355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison and Analysis of Two Internationally Recognized Biobanking Standards.
    Tarling T; O'Donoghue S; Barnes R; Carvalho K; Gali B; Castelhano M; Mes-Masson AM; Watson PH
    Biopreserv Biobank; 2020 Apr; 18(2):82-89. PubMed ID: 31985265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biobanking and Privacy Laws in Australia.
    Chalmers D
    J Law Med Ethics; 2015; 43(4):703-13. PubMed ID: 26711411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Securing the sustainability of biobanks].
    Kirsten R; Hummel M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):390-5. PubMed ID: 26769112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. China Biobanking.
    Zhang Y; Li Q; Wang X; Zhou X
    Adv Exp Med Biol; 2015; 864():125-40. PubMed ID: 26420618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.